UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 262

Sortiert nach

Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells

Frontiers in oncology, 2019-11, Vol.9, p.1202-1202

2019

Volltextzugriff (PDF)

Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients

Pharmacological research, 2022-07, Vol.181, p.106290-106290, Article 106290

2022

Volltextzugriff (PDF)

Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer

Cancer letters, 2017-12, Vol.411, p.35-43

2017

Volltextzugriff (PDF)

Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach

Pharmaceuticals (Basel, Switzerland), 2021-09, Vol.14 (10), p.995

2021

Volltextzugriff (PDF)

Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo

Oncology reports, 2018-05, Vol.39 (5), p.2225-2234

2018

Volltextzugriff (PDF)

Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma

Journal of clinical medicine, 2022-12, Vol.11 (23), p.7162

2022

Volltextzugriff (PDF)

Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward

Angiogenesis, 2015-10, Vol.18 (4), p.397-432

2015

Volltextzugriff (PDF)

Correction: Bocci et al. Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma. J. Clin. Med. 2022, 11, 7162

Journal of clinical medicine, 2023-11, Vol.12 (22), p.7053

2023

Volltextzugriff (PDF)

Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1

The journal of clinical endocrinology and metabolism, 2013-09, Vol.98 (9), p.E1465-E1473

2013

Volltextzugriff (PDF)

Predictive Power of Tissue and Circulating Biomarkers for the Severity of Biopsy-Validated Chronic Liver Diseases

Journal of clinical medicine, 2022-10, Vol.11 (20), p.5985

2022

Volltextzugriff (PDF)

Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer

Clinical cancer research, 2009-08, Vol.15 (15), p.4954-4962

2009

Volltextzugriff (PDF)

Metronomic Ceramide Analogs Inhibit Angiogenesis in Pancreatic Cancer through Up-regulation of Caveolin-1 and Thrombospondin-1 and Down-regulation of Cyclin D1

Neoplasia (New York, N.Y.), 2012-09, Vol.14 (9), p.833-IN11

2012

Volltextzugriff (PDF)

Irinotecan Synergistically Enhances the Antiproliferative and Proapoptotic Effects of Axitinib In Vitro and Improves Its Anticancer Activity In Vivo

Neoplasia (New York, N.Y.), 2011-03, Vol.13 (3), p.217-IN3

2011

Volltextzugriff (PDF)

Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration

Pharmacogenomics, 2012-07, Vol.13 (9), p.1037-1053

2012

Volltextzugriff (PDF)

The rs2071559 AA VEGFR-2 Genotype Frequency Is Significantly Lower in Neovascular Age-Related Macular Degeneration Patients

TheScientificWorld, 2012-01, Vol.2012, p.420190-6

2012

Volltextzugriff (PDF)

Metronomic Chemotherapy in Elderly Patients

Current oncology reports, 2024-04, Vol.26 (4), p.359-376

2024

Volltextzugriff (PDF)

Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly/FRAIL Patients, with Diffuse Large B-Cell Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.3796-3797

2022

Volltextzugriff (PDF)

Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib

Biochemical pharmacology, 2024-01, Vol.219, p.115952-115952, Article 115952

2024

Volltextzugriff (PDF)

Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer

Medical oncology (Northwood, London, England), 2020-03, Vol.37 (3), p.19-19, Article 19

2020

Volltextzugriff (PDF)

Metronomic vinorelbine is directly active on Non Small Cell Lung Cancer cells and sensitizes the EGFRL858R/T790M cells to reversible EGFR tyrosine kinase inhibitors

Biochemical pharmacology, 2018-06, Vol.152, p.327-337

2018

Volltextzugriff (PDF)

Active metronomic vinorelbine schedules decrease plasma interleukin-2 levels in mice with Lewis lung carcinoma

Journal of chemotherapy (Florence), 2021-05, Vol.33 (3), p.198-202

2021

Volltextzugriff (PDF)

Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics

Biochemical pharmacology, 2019-06, Vol.164, p.94-105

2019

Volltextzugriff (PDF)

Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer

Pharmacological research, 2020-08, Vol.158, p.104920-104920, Article 104920

2020

Volltextzugriff (PDF)

1 – 25 von 262

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(244)
Mit Volltextzugriff
(239)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells

Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients

Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer

Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach

Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo

Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma

Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward

Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy

Correction: Bocci et al. Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma. J. Clin. Med. 2022, 11, 7162

Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1

Predictive Power of Tissue and Circulating Biomarkers for the Severity of Biopsy-Validated Chronic Liver Diseases

Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer

Metronomic Ceramide Analogs Inhibit Angiogenesis in Pancreatic Cancer through Up-regulation of Caveolin-1 and Thrombospondin-1 and Down-regulation of Cyclin D1

A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients

Irinotecan Synergistically Enhances the Antiproliferative and Proapoptotic Effects of Axitinib In Vitro and Improves Its Anticancer Activity In Vivo

Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration

The rs2071559 AA VEGFR-2 Genotype Frequency Is Significantly Lower in Neovascular Age-Related Macular Degeneration Patients

Metronomic Chemotherapy in Elderly Patients

Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly/FRAIL Patients, with Diffuse Large B-Cell Lymphoma

Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib

Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer

Metronomic vinorelbine is directly active on Non Small Cell Lung Cancer cells and sensitizes the EGFRL858R/T790M cells to reversible EGFR tyrosine kinase inhibitors

Active metronomic vinorelbine schedules decrease plasma interleukin-2 levels in mice with Lewis lung carcinoma

Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics

Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer

Suchergebnisse filtern